Apr 03, 2017 8:00am EDT Sutro ADC Targeting CD74 Eradicates B-Cell Hematologic Malignancy, Prolongs Survival in Tumor Models
Dec 06, 2016 8:00am EST Sutro ADC Targeting CD74 Exhibits Potent Anti-tumor Activity in Multiple Malignant Cell Lines and Animal Models of Non-Hodgkin Lymphoma and Multiple Myeloma
Sep 19, 2016 8:00am EDT Sutro ADCs Targeting CD74 Suppress Tumors in Multiple Malignant Cell Lines and Animal Models of Multiple Myeloma and Non-Hodgkin Lymphoma
Sep 07, 2016 8:00am EDT Sutro Marks Important Progress -- Receives Two Milestone Payments from Celgene
Mar 09, 2016 10:00am EST Sutro Expands Senior Leadership Team with Addition of Chief Medical Officer and VP of Translational Pharmacology and Preclinical Development
Nov 18, 2015 9:00am EST Sutro Biopharma Receives the Pantheon 2015 DiNA Outstanding Partner Award by the California Life Sciences Association
Aug 04, 2015 9:00am EDT Sutro Biopharma Appoints Nicki Vasquez, Ph.D. as VP of Alliance and Project Management
